Dark | Light
# Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics announces a 12-part media series with New to The Street, aiming to boost visibility among investors and healthcare professionals. The company's FDA-cleared device for sleep apnea is highlighted as a non-surgical alternative to CPAP.

### About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a biotechnology company focused on developing and commercializing treatments for sleep-related breathing disorders.  
Vivos Therapeutics, Inc. uses the ticker $VVOS for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Vivos Therapeutics, Inc. (VVOS) social dominance is up 1420% from the previous [--] months.
- Vivos Therapeutics, Inc. (VVOS) mentions is up 15.26% from the previous week.
- Vivos Therapeutics, Inc. (VVOS) posts created is up 123.53% from the previous week.

### Price: $1.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/close.tsv)  
The current price action appears to be driven by anticipation of a breakout, with traders observing accumulation patterns below key resistance levels, supported by mentions of its low P/S ratio and significant institutional buying.  

24-Hour: -6.45%
7-Day: -2.29%
30-Day: -26.57%

1-Year High: $7 on 2025-07-14  
1-Year Low: $1.50 on 2026-02-04  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/alt_rank.tsv)  
Vivos Therapeutics, Inc. (VVOS) is currently AltRank #1,436 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,305  
1-Year High: [-----] on 2026-01-28  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +11  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2026-02-05  
1-Year Low: [--] on 2025-03-01  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +4.20%  
[--] Month: [-------] +0.67%  
[--] Months: [---------] -55%  
[--] Year: [---------] +5.30%  
1-Year High: [-------] on 2025-06-26  
1-Year Low: [--] on 2025-06-08  

Engagements by network (24h):
News: [--]
Reddit: [--]
TikTok: [--]
YouTube: [---]
X: [-----]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +15%  
1-Year High: [-----] on 2025-07-06  
1-Year Low: [--] on 2025-04-20  

Mentions by network (24h):
News: [--]
Reddit: [--]
TikTok: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Vivos Therapeutics, Inc. (VVOS) in the last [--] hours which is up 4.90% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +8.70%  
1-Year High: [-----] on 2025-07-04  
1-Year Low: [--] on 2025-04-20  

The most influential creators that mention Vivos Therapeutics, Inc. in the last [--] hours

| Creator                                                | Rank | Followers | Posts | Engagements |
| -------                                                | ---- | --------- | ----- | ----------- |
| [@mariostario2019](/creator/twitter/mariostario2019)   | [--]    | [--]        | [--]     | [---]         |
| [@newtothestreettv](/creator/youtube/newtothestreettv) | [--]    | [---------] | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)             | [--]    | [--]        | [--]     | [---]         |
| [@jobra555](/creator/twitter/jobra555)                 | [--]    | [---]       | [--]     | [---]         |
| [@NewToTheStreet](/creator/twitter/NewToTheStreet)     | [--]    | [------]    | [--]     | [--]          |
| [@MiriamF24887120](/creator/twitter/MiriamF24887120)   | [--]    | [--]        | [--]     | [--]          |
| [@ACInvestorBlog](/creator/twitter/ACInvestorBlog)     | [--]    | [-------]   | [--]     | [--]          |
| [@AlisonH65241148](/creator/twitter/AlisonH65241148)   | [--]    | [--]        | [--]     | [--]          |
| [@ElsaPhe22932079](/creator/twitter/ElsaPhe22932079)   | [--]    | [---]       | [--]     | [--]          |
| [@GuzmanAlic16045](/creator/twitter/GuzmanAlic16045)   | [--]   | [--]        | [--]     | [--]          |

[View More](/list/creators/$vvos/100)
  
  
### Sentiment: 93%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/sentiment.tsv)  
Current Value: 93%  
Daily Average: 85%  
[--] Week: 100% no change  
[--] Month: 90% +4%  
[--] Months: 90% +34%  
[--] Year: 90% +34%  
1-Year High: 100% on 2025-02-17  
1-Year Low: 15% on 2025-09-01  

Most Supportive Themes:
- Accumulation and Potential Pump: (40%) VVOS is currently in an accumulation phase, with expectations of a significant price increase once it surpasses certain resistance levels.
- Inclusion in Diverse Stock/Crypto Lists: (30%) VVOS is frequently mentioned alongside a wide array of other stocks and cryptocurrencies, indicating its presence in broader market discussions and watchlists.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.00822%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/social_dominance.tsv)  
Current Value: 0.00822%  
Daily Average: 0.012%  
[--] Week: 0.00793% +0.00563%  
[--] Month: 0.015% +0.0096%  
[--] Months: 0.015% -0.0004999999999999987%  
[--] Year: 0.015% +0.0068%  
1-Year High: 0.187% on 2025-07-06  
1-Year Low: 0.0002% on 2025-04-20  
  
  
### Market Dominance: 0.000019657933176068772%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/market_dominance.tsv)  
Current Value: 0.000019657933176068772%  
Daily Average: 0%  
1-Year High: 0.00082% on 2026-02-06  
1-Year Low: 0.00002% on 2026-02-14  
  
  
### Market Cap: $17,358,619
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$vvos/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$vvos/time-series/market_cap.tsv)  
Current Value: $17,358,619  
Daily Average: $19,909,118  
[--] Week: $16,559,209 -6.80%  
[--] Month: $17,358,619 -29%  
1-Year High: $24,439,108 on 2026-01-15  
1-Year Low: $17,130,216 on 2026-02-04  

### Top Vivos Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"What a gift get in prior institutions I lost big trusting con men $NIXX $FNGR $VVOS here is the win $NTRP Thank you @ChrisLaCoursie1 $NTRP alert after closing GoUSA and launch KCGlobal this is now a paradigm like $JFB $GRRR trading at $3 NOTE next week accredited investors dinner ONLY opportunity is for them to buy open market. Unbelievable retail can buy today. IMO multiple catalyst pending gamechanger OTA https://t.co/X7r1dJepeH $NTRP alert after closing GoUSA and launch KCGlobal this is now a paradigm like $JFB $GRRR trading at $3 NOTE next week accredited investors dinner ONLY opportunity"  
[X Link](https://x.com/1975aabc/status/2022379351782662310) [@1975aabc](/creator/x/1975aabc) 2026-02-13T18:36Z [--] followers, [---] engagements


"Wife wants a new boob job $PRTG $OMEX $VERA $LUNR $VVOS $VVPR $APLT $CURR $AMC $GME $SPY $ALZN $SNES $SERV $QNRX $CNEY $BCTX $QH $FTCI $TANH $SXTC $PLCE $SMTK $BKYI $LITM $RAYA $SGN $INM $GNPX $SYRA $BAOS $EAST $IVP $ASTS $DJT $AMC $GME $WHLR $BOIL $APLD $YYGH INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET"  
[X Link](https://x.com/BuyTheUgly/status/2022348225831666156) [@BuyTheUgly](/creator/x/BuyTheUgly) 2026-02-13T16:32Z [--] followers, [---] engagements


"Vivos Treats Sleep Apnea Without CPAP FDA-Cleared Device Expands Airway Non-Surgically For healthcare investors and patients seeking alternatives to CPAP this New to The Street interview features Kirk Huntsman CEO of Vivos Therapeutics explaining how the companys FDA-cleared oral appliance and integrated treatment protocol remodel the human airway non-surgically to treat obstructive sleep apnea in adults and children a condition affecting nearly [---] million Americans and linked to diabetes cardiovascular disease dementia and other comorbidities while offering a one-time treatment completed in"  
[YouTube Link](https://youtube.com/watch?v=zVE-2DFMkk4) [@newtothestreettv](/creator/youtube/newtothestreettv) 2026-02-11T23:16Z 4.3M followers, [---] engagements


"Vivos Therapeutics Signs 12-Part Media Series With New to The Street Sleep Tech Growth NewsOut Healthcare and medtech investors: Vivos Therapeutics a medical technology company focused on innovative treatments for breathing and sleep disorders has signed a 12-part media series agreement with New to The Street a long-running business television and digital media platform. Reporting from the New York Stock Exchange Jane King explains that the 12-month series will expand Vivos visibility among investors healthcare professionals and strategic partners through a multi-channel strategy spanning"  
[YouTube Link](https://youtube.com/watch?v=b68SauLJLIY) [@newtothestreettv](/creator/youtube/newtothestreettv) 2026-02-05T13:02Z 4.3M followers, 37.9K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics announces a 12-part media series with New to The Street, aiming to boost visibility among investors and healthcare professionals. The company's FDA-cleared device for sleep apnea is highlighted as a non-surgical alternative to CPAP.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. is a biotechnology company focused on developing and commercializing treatments for sleep-related breathing disorders.
Vivos Therapeutics, Inc. uses the ticker $VVOS for trading. Listed in the Stocks category.

Insights

  • Vivos Therapeutics, Inc. (VVOS) social dominance is up 1420% from the previous [--] months.
  • Vivos Therapeutics, Inc. (VVOS) mentions is up 15.26% from the previous week.
  • Vivos Therapeutics, Inc. (VVOS) posts created is up 123.53% from the previous week.

Price: $1.50

Price Line Chart
Price 24-Hour Time-Series Raw Data
The current price action appears to be driven by anticipation of a breakout, with traders observing accumulation patterns below key resistance levels, supported by mentions of its low P/S ratio and significant institutional buying.

24-Hour: -6.45% 7-Day: -2.29% 30-Day: -26.57%

1-Year High: $7 on 2025-07-14
1-Year Low: $1.50 on 2026-02-04

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Vivos Therapeutics, Inc. (VVOS) is currently AltRank #1,436 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +1,305
1-Year High: [-----] on 2026-01-28
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +11
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-02-05
1-Year Low: [--] on 2025-03-01

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +4.20%
[--] Month: [-------] +0.67%
[--] Months: [---------] -55%
[--] Year: [---------] +5.30%
1-Year High: [-------] on 2025-06-26
1-Year Low: [--] on 2025-06-08

Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [---] X: [-----]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
[--] Week: [---] +15%
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-04-20

Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [--] X: [---]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Vivos Therapeutics, Inc. (VVOS) in the last [--] hours which is up 4.90% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] +8.70%
1-Year High: [-----] on 2025-07-04
1-Year Low: [--] on 2025-04-20

The most influential creators that mention Vivos Therapeutics, Inc. in the last [--] hours

Creator Rank Followers Posts Engagements
@mariostario2019 [--] [--] [--] [---]
@newtothestreettv [--] [---------] [--] [---]
@BuyTheUgly [--] [--] [--] [---]
@jobra555 [--] [---] [--] [---]
@NewToTheStreet [--] [------] [--] [--]
@MiriamF24887120 [--] [--] [--] [--]
@ACInvestorBlog [--] [-------] [--] [--]
@AlisonH65241148 [--] [--] [--] [--]
@ElsaPhe22932079 [--] [---] [--] [--]
@GuzmanAlic16045 [--] [--] [--] [--]

View More

Sentiment: 93%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 93%
Daily Average: 85%
[--] Week: 100% no change
[--] Month: 90% +4%
[--] Months: 90% +34%
[--] Year: 90% +34%
1-Year High: 100% on 2025-02-17
1-Year Low: 15% on 2025-09-01

Most Supportive Themes:

  • Accumulation and Potential Pump: (40%) VVOS is currently in an accumulation phase, with expectations of a significant price increase once it surpasses certain resistance levels.
  • Inclusion in Diverse Stock/Crypto Lists: (30%) VVOS is frequently mentioned alongside a wide array of other stocks and cryptocurrencies, indicating its presence in broader market discussions and watchlists.

Most Critical Themes:

Social Dominance: 0.00822%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00822%
Daily Average: 0.012%
[--] Week: 0.00793% +0.00563%
[--] Month: 0.015% +0.0096%
[--] Months: 0.015% -0.0004999999999999987%
[--] Year: 0.015% +0.0068%
1-Year High: 0.187% on 2025-07-06
1-Year Low: 0.0002% on 2025-04-20

Market Dominance: 0.000019657933176068772%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.000019657933176068772%
Daily Average: 0%
1-Year High: 0.00082% on 2026-02-06
1-Year Low: 0.00002% on 2026-02-14

Market Cap: $17,358,619

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $17,358,619
Daily Average: $19,909,118
[--] Week: $16,559,209 -6.80%
[--] Month: $17,358,619 -29%
1-Year High: $24,439,108 on 2026-01-15
1-Year Low: $17,130,216 on 2026-02-04

Top Vivos Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"What a gift get in prior institutions I lost big trusting con men $NIXX $FNGR $VVOS here is the win $NTRP Thank you @ChrisLaCoursie1 $NTRP alert after closing GoUSA and launch KCGlobal this is now a paradigm like $JFB $GRRR trading at $3 NOTE next week accredited investors dinner ONLY opportunity is for them to buy open market. Unbelievable retail can buy today. IMO multiple catalyst pending gamechanger OTA https://t.co/X7r1dJepeH $NTRP alert after closing GoUSA and launch KCGlobal this is now a paradigm like $JFB $GRRR trading at $3 NOTE next week accredited investors dinner ONLY opportunity"
X Link @1975aabc 2026-02-13T18:36Z [--] followers, [---] engagements

"Wife wants a new boob job $PRTG $OMEX $VERA $LUNR $VVOS $VVPR $APLT $CURR $AMC $GME $SPY $ALZN $SNES $SERV $QNRX $CNEY $BCTX $QH $FTCI $TANH $SXTC $PLCE $SMTK $BKYI $LITM $RAYA $SGN $INM $GNPX $SYRA $BAOS $EAST $IVP $ASTS $DJT $AMC $GME $WHLR $BOIL $APLD $YYGH INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET YET While most investors chase headlines the smart money inside Prairie Operating Co. has been quietly building massive positions. Key insiders control a significant chunk of the float Leadership and major holders own https://t.co/Y81oDJoJEm INSIDERS ARE LOADING $PROP WHY ISNT WALL STREET"
X Link @BuyTheUgly 2026-02-13T16:32Z [--] followers, [---] engagements

"Vivos Treats Sleep Apnea Without CPAP FDA-Cleared Device Expands Airway Non-Surgically For healthcare investors and patients seeking alternatives to CPAP this New to The Street interview features Kirk Huntsman CEO of Vivos Therapeutics explaining how the companys FDA-cleared oral appliance and integrated treatment protocol remodel the human airway non-surgically to treat obstructive sleep apnea in adults and children a condition affecting nearly [---] million Americans and linked to diabetes cardiovascular disease dementia and other comorbidities while offering a one-time treatment completed in"
YouTube Link @newtothestreettv 2026-02-11T23:16Z 4.3M followers, [---] engagements

"Vivos Therapeutics Signs 12-Part Media Series With New to The Street Sleep Tech Growth NewsOut Healthcare and medtech investors: Vivos Therapeutics a medical technology company focused on innovative treatments for breathing and sleep disorders has signed a 12-part media series agreement with New to The Street a long-running business television and digital media platform. Reporting from the New York Stock Exchange Jane King explains that the 12-month series will expand Vivos visibility among investors healthcare professionals and strategic partners through a multi-channel strategy spanning"
YouTube Link @newtothestreettv 2026-02-05T13:02Z 4.3M followers, 37.9K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Vivos Therapeutics, Inc. (VVOS)
/topic/$vvos